$2.08 -0.01 (-0.72%)
11/27/2009 11:13 AM

Corcept Therapeutics, Inc. (CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Featured Broker Partners